|
Volumn 49, Issue 1270, 2007, Pages 77-78
|
Pregabalin (Lyrica) for fibromyalgia
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
ANALGESIC AGENT;
DULOXETINE;
GABAPENTIN;
MUSCLE RELAXANT AGENT;
PIOGLITAZONE;
PREGABALIN;
SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;
SEROTONIN UPTAKE INHIBITOR;
4 AMINOBUTYRIC ACID;
DRUG DERIVATIVE;
ANGIONEUROTIC EDEMA;
ATAXIA;
BLURRED VISION;
CLINICAL TRIAL;
COGNITIVE THERAPY;
CONSTIPATION;
DIZZINESS;
DRUG APPROVAL;
DRUG CLEARANCE;
DRUG COST;
DRUG MARKETING;
DRUG WITHDRAWAL;
EUPHORIA;
EXERCISE;
FATIGUE;
FIBROMYALGIA;
HUMAN;
ISCHIALGIA;
NEUROPATHIC PAIN;
OFF LABEL DRUG USE;
PERIPHERAL EDEMA;
RECOMMENDED DRUG DOSE;
SEIZURE;
SHORT SURVEY;
SIDE EFFECT;
SLEEP DISORDER;
WEIGHT GAIN;
XEROSTOMIA;
ARTICLE;
DRUG ADMINISTRATION;
DRUG INTERACTION;
ECONOMICS;
ORAL DRUG ADMINISTRATION;
PAIN;
PAIN ASSESSMENT;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ANALGESICS;
DRUG ADMINISTRATION SCHEDULE;
DRUG COSTS;
DRUG INTERACTIONS;
FIBROMYALGIA;
GAMMA-AMINOBUTYRIC ACID;
HUMANS;
PAIN;
PAIN MEASUREMENT;
TREATMENT OUTCOME;
|
EID: 35148866972
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (7)
|
References (7)
|